S-1/A: BioRestorative Therapies Files Amendment No. 1 to Form S-1 Registration Statement
S-1/A Amendment
BioRestorative Therapies, Inc. files an amendment to its Form S-1 registration statement to include additional exhibits related to its corporate structure, agreements, and legal opinions.
Summary
- BioRestorative Therapies, Inc. has filed Amendment No. 1 to its Form S-1 registration statement with the Securities and Exchange Commission on April 12, 2024.
- This amendment primarily includes additional exhibits, such as amended articles of incorporation, certificate of designations, bylaws, license agreements, employment agreements, stock option award agreements, and legal opinions.
- The original prospectus and the balance of Part II of the Registration Statement remain unchanged.
- The company intends to commence the proposed sale to the public as soon as practicable after the effective date of the registration statement.
Sentiment
Score: 6
Explanation: The document is a regulatory filing, so the sentiment is neutral. It's a necessary step for the company's plans to offer securities.
Future Outlook
The company intends to proceed with a proposed sale to the public as soon as practicable after the effective date of this registration statement.
Industry Context
This filing is a standard step for companies preparing to offer securities to the public, ensuring regulatory compliance and providing necessary information to potential investors.
Stakeholder Impact
- Potential investors will have access to updated information about the company.
- The company's ability to raise capital may be affected by the effectiveness of the registration statement.
Next Steps
- The SEC will review the amended registration statement.
- The company will proceed with the public offering after the registration statement becomes effective.
Key Dates
| Date | Description |
|---|---|
| January 27, 2012 | Date of License Agreement between Regenerative Sciences, LLC and BioRestorative Therapies, Inc. |
| March 21, 2012 | Date of Amendment to License Agreement. |
| August 25, 2014 | Date of Lease between BioRestorative Therapies, Inc. and 50 Republic Road, LLC. |
| November 30, 2015 | Date of Amendment to License Agreement. |
| March 18, 2021 | Date of Executive Employment Agreements with Lance Alstodt and Francisco Silva. |
| November 4, 2021 | Date of Executive Employment Agreement with Robert Kristal and various Stock Option Award Agreements. |
| November 9, 2021 | Date of Common Stock Purchase Warrant issued pursuant to public offering. |
| December 10, 2021 | Date of Amendment No. 2 to Non-Qualified Stock Option Award Agreements. |
| December 29, 2021 | Date of Executive Employment Agreement with Robert Paccasassi. |
| December 29, 2022 | Date of Amended and Restated Articles of Incorporation and Certificate of Designations of Series B Preferred Stock. |
| November 21, 2022 | Date of Letter agreement by and among BioRestorative Therapies, Inc., Regenerative Sciences, LLC and Regenexx, LLC with regard to License Agreement |
| February 17, 2023 | Date of Incentive Stock Option Award Agreements. |
| April 14, 2023 | Date of Capital on Demand Sales Agreement with JonesTrading Institutional Services LLC. |
| February 5, 2024 | Date of Form of Agreement by and between the Company and Auctus Fund, LLC. |
| February 6, 2024 | Date of Form of Agreement by and between the Company and the warrantholders (other than Auctus Fund, LLC). |
| February 13, 2024 | Date of Incentive and Non-Qualified Stock Option Award Agreements. |
| April 12, 2024 | Date of Amendment No. 1 filing. |
Keywords
Form S-1, Registration Statement, Amendment, Exhibits, Securities, BioRestorative Therapies, Offering
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.